Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy.
Ballester MP, Gallego JJ, Fiorillo A, Casanova-Ferrer F, Giménez-Garzó C, Escudero-García D, Tosca J, Ríos MP, Montón C, Durbán L, Ballester J, Benlloch S, Urios A, San-Miguel T, Kosenko E, Serra MÁ, Felipo V, Montoliu C.
Ballester MP, et al.
Sci Rep. 2022 Feb 14;12(1):2463. doi: 10.1038/s41598-022-06416-z.
Sci Rep. 2022.
PMID: 35165326
Free PMC article.